Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes.

P. Schrauwen*, M.K.C. Hesselink, E.E. Blaak, L. Borghouts, G. Schaart, W.H.M. Saris, H.A. Keizer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

238 Downloads (Pure)


Diabetes 2001 Dec;50(12):2870-3 Related Articles, Books, LinkOut

Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes.

Schrauwen P, Hesselink MK, Blaak EE, Borghouts LB, Schaart G, Saris WH, Keizer HA.

Department of Human Biology, Maastricht University, Maastricht, the Netherlands. p.schrauwen@hb.unimaas.nl

Recently, a role for uncoupling protein-3 (UCP3) in carbohydrate metabolism and in type 2 diabetes has been suggested. Mice overexpressing UCP3 in skeletal muscle showed reduced fasting plasma glucose levels, improved glucose tolerance after an oral glucose load, and reduced fasting plasma insulin levels. However, data regarding the expression of UCP3 in patients with type 2 diabetes is inconsistent, and so far, there have been no reports of UCP3 protein content. Here we compared, for the first time, the protein levels of UCP3 in vastus lateralis muscle in 14 male type 2 diabetic patients (age 49.8 +/- 2.1 years; BMI 27.2 +/- 1.2 kg/m(2); mean +/- SE) with 16 male control subjects (age 48.0 +/- 1.9 years; BMI 23.4 +/- 0.6 kg/m(2)). We found that UCP3 protein levels were twice as low in patients with type 2 diabetes compared with control subjects (117 +/- 16 vs. 58 +/- 12 AU; P = 0.007). There was no correlation between UCP3 content and BMI. In conclusion, UCP3 content is lower in type 2 diabetic patients compared with healthy control subjects. These results are consistent with a role for UCP3 in glucose homeostasis and suggest a role for UCP3 in type 2 diabetes.

Original languageEnglish
Pages (from-to)2870-2873
Number of pages4
Publication statusPublished - 1 Jan 2001

Cite this